Title: |
The OP-104 Anchor Study: A Phase 1/2 Study of Safety and Efficacy of Melflufen and Dexamethasone in Combination with Either Bortezomib or Daratumumab in Patients with Rrmm; First Report on Phase 1 Data |
Source: |
Blood
[0006-4971]
Pour,
Ludek
yr:2018
|
|
|
|